Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease-Reference-Cited by-同舟云学术

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease

Published:2016-11-16 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kim Jin Hyang,Reber Adrian J.,Kumar Amrita,Ramos Patricia,Sica Gabriel,Music Nedzad,Guo Zhu,Mishina Margarita,Stevens James,York Ian A.,Jacob Joshy,Sambhara Suryaprakash

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep37341.pdf

Reference80 articles.

1. Novel Swine-Origin Influenza, A. V. I. T. et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360, 2605–2615, doi: 10.1056/NEJMoa0903810 (2009).

2. Chan, M. World now at the start of 2009 influenza pandemic. state to the press by WHO director (2009).

3. Shrestha, S. S. et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 52 Suppl 1, S75–S82, doi: 10.1093/cid/ciq012 (2011).

4. Fowlkes, A. L. et al. Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. Clin Infect Dis 52 Suppl 1, S60–S68, doi: 10.1093/cid/ciq022 (2011).

5. Dawood, F. S. et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12, 687–695, doi: 10.1016/S1473-3099(12)70121-4 (2012).

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained vaccine exposure elicits more rapid, consistent, and broad humoral immune responses to multivalent influenza vaccines;2024-04-30

2. Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection;Antibodies;2024-04-03

3. Variation in the basal immune state and implications for disease;eLife;2024-01-26

4. Protective mechanisms of nonneutralizing antiviral antibodies;PLOS Pathogens;2023-10-05

5. COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies;Medical Hypotheses;2022-10